A woman peacefully sleeping on a bed, conveying relaxation and comfort.
Photo by Los Muertos Crew on Pexels
i
How we researched this
This review synthesizes 18 published clinical studies including meta-analyses of screening tool performance, cohort studies on sex-specific presentations, and systematic reviews of snoring etiology. We did not test products in-house. Full methodology

What causes snoring (and why the answer matters)

What causes snoring is straightforward at the mechanical level: during sleep, the muscles supporting your airway relax, soft tissue vibrates as air moves past, and you produce sound. The clinical question is whether that vibration happens in an otherwise normal airway (primary snoring) or in an airway that periodically collapses and stops breathing (obstructive sleep apnea, OSA). 1

Primary snoring involves the same anatomical structures: soft palate, uvula, tongue base, lateral pharyngeal walls. The upstream triggers overlap as well. Nasal obstruction from allergic rhinitis increases snoring risk. 16 Alcohol relaxes pharyngeal muscle tone and worsens snoring severity. 2 Visceral obesity narrows the airway and increases tissue bulk. 17 Elevated fasting insulin, even in otherwise healthy adults, associates with snoring independent of body mass index. 3

The problem for self-diagnosis is that these risk factors predict both conditions. A 44-year-old male with a BMI of 31, seasonal allergies, and nightly snoring after two beers could have simple snoring or moderate OSA. The symptom profile does not reliably separate them.

This matters because the health implications diverge sharply. Primary snoring carries metabolic risk (even benign snoring associates with elevated triglycerides), 9 but obstructive sleep apnea drives cardiovascular disease, stroke, pulmonary hypertension, and all-cause mortality. 10 11 12 The louder you snore does not predict which category you fall into.

Primary snoring doesn’t look that different from sleep apnea

Popular advice frames snoring and sleep apnea as clinically distinct: snorers are told to look for witnessed apneas, morning headaches, or severe daytime sleepiness. If those symptoms are absent, the assumption is reassurance. The evidence complicates that framing.

Mild to moderate OSA often presents with the same symptom burden as primary snoring. Loud snoring, yes. Fragmented sleep, sometimes. Witnessed apneas, only if a bed partner is observant and awake during the event. Daytime sleepiness, common in both groups and heavily influenced by sleep duration, shift work, caffeine intake, and a dozen non-respiratory variables. Morning headache, present in fewer than 30% of confirmed OSA cases.

The table below shows the clinical feature overlap reported in systematic reviews and large cohort studies.

Feature Primary Snoring Mild-Moderate OSA Severe OSA
Loud snoring Present Present Present
Witnessed apneas Rare Occasional Frequent
Daytime sleepiness Variable Variable Common
Morning headache Rare Variable Present in <30%
Obesity (BMI >30) Common Common Very common
Nasal obstruction Common Common Common

Clinical features of primary snoring vs obstructive sleep apnea. Mild-moderate OSA overlaps substantially with benign snoring. Data from systematic reviews and cohort studies.

The distinction that matters clinically is the apnea-hypopnea index (AHI), the number of breathing pauses or reductions per hour of sleep, measured by polysomnography. Primary snoring: AHI less than 5. Mild OSA: 5 to 15. Moderate: 15 to 30. Severe: greater than 30. You cannot derive that number from a questionnaire filled out in your kitchen.

What causes snoring in women looks different on a questionnaire

Is snoring dangerous in the same way for men and women? The pathophysiology is similar, but the clinical presentation diverges enough that screening tools designed on male cohorts systematically miss cases.

Women with OSA report different symptom clusters. Instead of the classic triad (loud snoring, witnessed apneas, severe sleepiness), women more often describe insomnia, morning fatigue, depression, and nocturnal choking sensations without loud snoring. 13 14 A 2026 review in Chest found that standard screening questionnaires, developed and validated primarily in male populations, fail to capture these sex-specific presentations. 15

What causes snoring in females also involves hormonal shifts that questionnaires ignore. Postmenopausal women show a steep rise in OSA prevalence, independent of weight gain. 13 Pregnancy, polycystic ovary syndrome, and thyroid dysfunction all modulate airway collapsibility and snoring risk in ways that male-derived screening tools do not query.

The result is diagnostic delay. Women with moderate OSA often score low on STOP-BANG (which weights neck circumference and loud snoring heavily, both less pronounced in women) and receive reassurance when they should receive a referral.

Why STOP-BANG and Epworth miss so many cases

Online snoring assessments typically rely on one of three tools: STOP-BANG, the Epworth Sleepiness Scale, or the Berlin Questionnaire. All three have published sensitivity and specificity data. None approach diagnostic accuracy.

A 2022 meta-analysis in Sleep and Breathing pooled performance data across multiple cohorts. Sensitivity (the ability to correctly identify OSA when present) ranged from 76% to 90% depending on the AHI cutoff. Specificity (the ability to correctly identify primary snoring when OSA is absent) fell as low as 35% to 54% in some populations. 6

Translation: in a cohort of 100 snorers where 40 have OSA and 60 have primary snoring, STOP-BANG at a score threshold of 3 or higher would correctly flag 36 of the 40 OSA cases (sensitivity 90%) but would also incorrectly flag 28 of the 60 benign snorers (specificity 54%). You end up with 64 positive screens, 28 of which are false positives. The positive predictive value in that scenario is 56%. A coin flip has better precision.

The Epworth Sleepiness Scale performs worse. Designed to measure daytime sleepiness, not airway obstruction, it misses the substantial fraction of OSA patients who do not report sleepiness. A 2017 bivariate meta-analysis found Epworth’s pooled sensitivity for OSA detection was 55%, meaning it missed nearly half the cases. 8

STOP-BANG performs better in surgical or sleep-clinic populations where OSA prevalence is high (60% to 80%), because positive predictive value increases with disease prevalence. In a general-population snorer with lower pretest probability, the same tool generates far more false positives. 4 5

✓
Key finding

A 2022 systematic review found that screening questionnaires for obstructive sleep apnea have pooled sensitivity around 80% but specificity as low as 50% in some clinical cohorts. In practical terms, half the people flagged as high-risk by an online quiz may not have sleep apnea, and the tools miss a meaningful fraction of those who do.

The US Preventive Services Task Force reviewed the evidence in 2022 and concluded that the accuracy of screening questionnaires is insufficient to support population-wide screening. The recommendation: screen only in high-risk groups, and confirm with objective testing. 7

The soft palate neuromuscular story most guides skip

What causes snoring at the tissue level involves more than relaxed muscle tone. A Cochrane review on myofunctional therapy for OSA documented that oropharyngeal muscle dysfunction, not just excess soft tissue, contributes to airway collapse. 18 Specific muscles lose coordination: the tensor veli palatini fails to stiffen the soft palate, the genioglossus weakens and allows posterior tongue displacement, the pharyngeal constrictors do not maintain lateral wall tension.

This matters because it explains why two people with identical neck circumference and BMI can have different snoring phenotypes. One has primary snoring driven by nasal congestion and supine sleep position. The other has mild OSA driven by neuromuscular fatigue that worsens across the night. Neither phenotype is obvious from a questionnaire asking about loud snoring and daytime sleepiness.

The neuromuscular angle also clarifies why alcohol has dose-dependent effects. A single drink may worsen snoring through soft-tissue relaxation without triggering apneas. Three drinks can push a compensated airway into intermittent collapse. 2 The dose-response is individual and not predicted by baseline snoring volume.

Mendelian randomization studies suggest causal links between insulin resistance and snoring, mediated through inflammatory pathways and adipose deposition in pharyngeal tissues. 3 This implies that even normal-weight snorers with metabolic syndrome face airway obstruction risk beyond what traditional risk scores capture.

When snoring signals something urgent

The conservative clinical stance is that all habitual snorers warrant evaluation if cardiovascular risk factors are present. But certain features elevate urgency.

Witnessed apneas longer than 10 seconds, occurring multiple times per night, predict moderate to severe OSA in more than 80% of cases when reported by a reliable bed partner. Waking up gasping or choking, distinct from coughing or clearing your throat, similarly suggests intermittent airway collapse.

Morning symptoms matter more than most online advice acknowledges. Waking with a dry mouth or sore throat every morning points to mouth breathing during sleep, often from chronic nasal obstruction or positional airway narrowing. Morning headaches that resolve within 30 minutes correlate with nocturnal hypercapnia (elevated CO2 from shallow breathing or apneas). 7

Daytime sleepiness that intrudes on safety is non-negotiable grounds for referral. If you have ever nodded off while driving, during a conversation, or while operating machinery, that alone justifies polysomnography regardless of snoring volume.

Less recognized: cognitive symptoms without sleepiness. Difficulty concentrating, memory lapses, or mood changes (irritability, low motivation) can reflect sleep fragmentation from repetitive arousals even when total sleep time seems adequate. Women in particular report these symptoms more often than frank sleepiness. 13

Cardiovascular history changes the calculation. A snorer with hypertension resistant to two medications, atrial fibrillation, prior stroke, or congestive heart failure has high enough OSA prevalence (50% to 70% in those cohorts) that screening moves from optional to indicated. 11

Skip the online quiz, get a referral

If you snore regularly (three or more nights per week), the evidence-based path is not a STOP-BANG score, it is a conversation with a physician who can order home sleep apnea testing or refer for in-lab polysomnography. Home testing (level 3 portable monitor) has sensitivity of 80% to 90% for moderate to severe OSA when scored by a sleep technologist, costs a fraction of in-lab study, and can be completed in two nights. 7

If the study confirms primary snoring (AHI less than 5, no significant oxygen desaturation), management targets modifiable risk factors: treating nasal obstruction, reducing alcohol intake, weight loss if BMI is elevated, avoiding supine sleep. Positional therapy (a device that keeps you off your back) reduces snoring frequency in about 50% of positional snorers.

For confirmed OSA, the treatment algorithm depends on severity and symptom burden. Mild OSA with minimal symptoms may start with conservative measures. Moderate to severe OSA typically requires positive airway pressure therapy (CPAP or auto-adjusting PAP), which remains the only intervention proven to reduce cardiovascular events in randomized trials. 7

Mandibular advancement devices, worn during sleep to hold the jaw forward and open the airway, have moderate-quality evidence for mild to moderate OSA when CPAP is refused or not tolerated. Devices like SnoreRX or ZQuiet fit this category. They work for primary snoring as well, but only after sleep apnea has been ruled out. A mouthpiece that eliminates snoring noise but leaves apneas untreated does not improve health outcomes.

The tension here is commercial: online retailers sell anti-snoring devices directly to consumers with no diagnostic requirement, marketed as solutions for “snoring and mild sleep apnea.” What causes snoring and what causes apneas overlap enough that self-treatment without testing is a gamble. You are paying $60 for a mouthpiece that might address primary snoring, or might mask apneas that need medical management.

✓
What to look for in a referral process

Ask your physician about home sleep apnea testing if you snore regularly. Home testing costs $150 to $300 out-of-pocket (often covered by insurance with a physician order), provides an AHI and oxygen saturation data, and can be completed in your own bed over two nights. If the home study is negative but symptoms persist, request in-lab polysomnography, which captures more nuanced sleep architecture and can diagnose conditions home testing misses. Do not rely on screening questionnaires as a substitute for objective testing.

Not affiliated with or endorsed by any cited organization.

Sources

  1. De Meyer MMD, et al. Systematic review of the different aspects of primary snoring. Sleep Med Rev, 2019. PubMed
  2. Burgos-Sanchez C, et al. Impact of Alcohol Consumption on Snoring and Sleep Apnea: A Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg, 2020. PubMed
  3. Yi M, et al. Elevated fasting insulin results in snoring: A view emerged from causal evaluation of glycemic traits and snoring. Eur J Clin Invest, 2022. PubMed
  4. Hwang M, et al. Validation of the STOP-Bang questionnaire as a preoperative screening tool for obstructive sleep apnea: a systematic review and meta-analysis. BMC Anesthesiol, 2022. PubMed
  5. Pivetta B, et al. Use and Performance of the STOP-Bang Questionnaire for Obstructive Sleep Apnea Screening Across Geographic Regions: A Systematic Review and Meta-Analysis. JAMA Netw Open, 2021. PubMed
  6. Bernhardt L, et al. Diagnostic accuracy of screening questionnaires for obstructive sleep apnoea in adults in different clinical cohorts: a systematic review and meta-analysis. Sleep Breath, 2022. PubMed
  7. Feltner C, et al. Screening for Obstructive Sleep Apnea in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA, 2022. PubMed
  8. Chiu HY, et al. Diagnostic accuracy of the Berlin questionnaire, STOP-BANG, STOP, and Epworth sleepiness scale in detecting obstructive sleep apnea: A bivariate meta-analysis. Sleep Med Rev, 2017. PubMed
  9. Hou FF, et al. Relationship between triglyceride levels and different snoring states: a systematic review and meta-analysis. Eur J Med Res, 2024. PubMed
  10. Titova OE, et al. Sleep-disordered breathing-related symptoms and risk of stroke: cohort study and Mendelian randomization analysis. J Neurol, 2022. PubMed
  11. Yang C, et al. Associations of sleep with cardiometabolic risk factors and cardiovascular diseases: An umbrella review of observational and mendelian randomization studies. Sleep Med Rev, 2024. PubMed
  12. Battaglia E, et al. Pulmonary hypertension in patients affected by sleep-related breathing disorders: up to date from the literature. Minerva Med, 2024. PubMed
  13. Bouloukaki I, et al. Advances in the Diagnosis and Treatment of Obstructive Sleep Apnea in Women. Pulm Ther, 2026. PubMed
  14. Pihtili A, et al. Sex differences in clinical and polysomnographic features of obstructive sleep apnea: The Turkish sleep apnea database (TURKAPNE) cohort. Sleep Med, 2025. PubMed
  15. Dunietz GL, et al. OSA in Women: Associations With Reproductive Aging and Screening Challenges. Chest, 2026. PubMed
  16. Liu J, et al. The association between allergic rhinitis and sleep: A systematic review and meta-analysis of observational studies. PLoS One, 2020. PubMed
  17. Song G, et al. Association of epicardial adipose tissues with obstructive sleep apnea and its severity: A meta-analysis study. Nutr Metab Cardiovasc Dis, 2020. PubMed
  18. Rueda JR, et al. Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea. Cochrane Database Syst Rev, 2020. PubMed
We cite primary research wherever possible. We are not affiliated with or endorsed by any cited organization.